Capital Research Global InvestorsCapital Research Global Investors

Institutional investor · Portfolio as of Q2 2022

Top Holdings423 positions

Checking export access…
Activity:

Microsoft Corp

84.3M$21.7B6.7%$102.28+142.50%
15 qtrssince 2018-Q4
Decreased
0

Amazon.com Inc

100.3M$10.7B3.3%$102.73+3.39%
15 qtrssince 2018-Q4
Increased
94

UnitedHealth Group Inc

19.2M$9.9B3.1%$246.38+92.33%
15 qtrssince 2018-Q4
Decreased
0

Broadcom Inc

20.2M$9.8B3.1%$22.17+104.89%
15 qtrssince 2018-Q4
Decreased
0

Abbott Laboratories

80.1M$8.7B2.7%$63.03+58.19%
15 qtrssince 2018-Q4
Decreased
0

United Technologies Corp

74.9M$7.2B2.2%$64.50+36.18%
10 qtrssince 2020-Q1
Increased
60

Philip Morris International In

66.4M$6.6B2.0%$53.69+52.00%
15 qtrssince 2018-Q4
Increased
55

Alphabet Inc

2.8M$6.2B1.9%$59.65+80.95%
15 qtrssince 2018-Q4
Decreased
0

Canadian Natural Resources Ltd

105.5M$5.7B1.8%$7.61+184.99%
15 qtrssince 2018-Q4
Decreased
0

Alphabet Inc

2.5M$5.5B1.7%$57.48+88.49%
15 qtrssince 2018-Q4
Decreased
0

General Electric Co

86.6M$5.5B1.7%$57.26-32.21%
4 qtrssince 2021-Q3
Increased
56

Comcast Corp

135.3M$5.3B1.7%$33.99-8.11%
15 qtrssince 2018-Q4
Decreased
0

Facebook Inc

31.1M$5B1.6%$146.18+9.26%
15 qtrssince 2018-Q4
Increased
52

Apple Inc

36.1M$4.9B1.5%$104.35+28.33%
15 qtrssince 2018-Q4
Decreased
0

Thermo Fisher Scientific Inc

8.7M$4.8B1.5%$243.47+120.32%
15 qtrssince 2018-Q4
Increased
50

AbbVie Inc

26.3M$4B1.3%$89.51+46.89%
15 qtrssince 2018-Q4
Increased
71
13.8M$4B1.2%$162.23+71.41%
15 qtrssince 2018-Q4
Increased
50

Mastercard Inc

12.2M$3.9B1.2%$219.23+40.27%
15 qtrssince 2018-Q4
Decreased
0

EOG Resources Inc

32.5M$3.6B1.1%$63.50+46.29%
15 qtrssince 2018-Q4
Increased
57

Gilead Sciences Inc

56M$3.5B1.1%$51.58+3.89%
15 qtrssince 2018-Q4
Increased
50
$321B
AUM
423
Positions
Q2 2022
Filing
HI score · 4.0/5
Quarterly 13F Value Change
+6%Q1'21$408.7B+5%Q2'21$429.5B-0%Q3'21$428.6B+6%Q4'21$452.7B-11%Q1'22$405.1B-21%Q2'22$321B
Activity profile
$ moved · Q2'22
New2%Increased34%Decreased60%Exited4%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 2.4 years
<1Q3%1-4Q14%1-2Y16%2Y+66%

Capital Research Global Investors manages $321B across 423 positions as of Q2 2022. Top holdings: MSFT (6.7%), AMZN (3.3%), UNH (3.1%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 4/5.0.

Q2 2022 Summary

Active quarter - 22 new positions, 39 exits, 190 increased. Top move: AMZN (INCREASED, conviction 94). Portfolio: $321.0B across 423 positions.

Top holdings by portfolio weight

Total AUM$321B
MSFT6.75%
AMZN3.32%
UNH3.08%
AVGO3.05%
ABT2.71%
RTX2.24%
PM2.04%
GOOGL1.92%
CNQ1.77%
GOOG1.72%
Other1.72%

Portfolio allocation by GICS sector

Sectors11
Technology18.90%
Healthcare16.28%
Consumer Cyclical11.22%
Industrials10.81%
Financial Services9.03%
Communication Services8.62%
Energy7.10%
Consumer Defensive6.16%
Utilities4.50%
Basic Materials2.96%
Other4.40%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Technology, Healthcare, Consumer Cyclical
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Strong(4.0 / 5.0)
Holdings P&L64
Conviction42
Concentration56
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
7Q
MOMOALTRIA GROUP INC
Q4 2024 → Q2 2026+46.6M shares+$3.6B
7Q
AEPAEPAMERICAN ELEC PWR CO INC
Q4 2024 → Q2 2026+62,748 shares+$58M
7Q
APHAPHAmphenol Corporation
Q4 2024 → Q2 2026+25.2M shares+$4.9B
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used